Evidence Points to GI Infection by SARS-CoV-2
Viral host receptor ACE2 stained positive mainly in cytoplasm of gastrointestinal epithelial cells
Thousands in U.S. May Already Be Infected With SARS-CoV-2
Preventive measures to reduce transmissibility of unidentified cases may have cut number of infected
Safety, Effectiveness of VKAs, DOACs Similar in General Practice
Risk for overall bleeding lower with vitamin K antagonists, but risk for mortality increased compared with DOACs
Risk Factors Linked to In-Hospital Death in COVID-19 Identified
Older age, higher score for organ failure, d-dimer >1 µg/mL linked to increased odds of in-hospital death
Many Clinicians Unaware of Invasive Pulmonary Aspergillosis
Galactomannan testing for ICU patients with severe influenza used always or very often by 8 percent
Details Provided for U.S. Person-to-Person Transmission of SARS-CoV-2
Person-to-person transmission reported between two people with prolonged unprotected exposure
Daily Rounding Helps Curb CAUTIs in Pediatric ICU Patients
Bundle of prevention strategies cut catheter-associated UTIs in peds ICU with sustained results
Typical Chest CT Findings Help Screen for Coronavirus Infection
Architectural distortion, traction bronchiectasis, CT involvement score aid in assessing disease severity
Median Incubation Period Estimated at 5.1 Days for COVID-19
Overall, 101 of 10,000 cases will develop symptoms after 14 days of active monitoring or quarantine
Guidelines Detail Management of Liver Failure in ICU Patients
29 recommendations address CV, hematology, pulmonary, renal, endocrine considerations
